Hongqin Zhuang
The State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Elovl6 inhibits colorectal cancer progression through stearic acid-mediated mitochondrial fusion and metabolic reprogramming.
Journal: Science advances
Published: February 13, 2026
New challenges in diagnosis and treatment of chest pain in the patient with hyperuricemia.
Journal: Rheumatology advances in practice
Published: January 05, 2026
Cationic Surface Modification Combined with Collagen Enhances the Stability and Delivery of Magnetosomes for Tumor Hyperthermia.
Journal: Journal of functional biomaterials
Published: October 31, 2025
Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signals.
Journal: Cell reports
Published: September 18, 2025
Modulating fatty acid signaling to restore allopregnanolone balance: a novel strategy for anxiety disorders.
Journal: Signal transduction and targeted therapy
Published: June 16, 2025
Metformin's hidden power: Unveiling its role in melanoma suppression through endo-lysosome pH and autophagy regulation.
Journal: European journal of pharmacology
Published: May 12, 2025
Precision tumor immunotherapy via a dual-gated macrophage-bacterial activation platform.
Journal: Trends in biotechnology
Published: March 28, 2025
Aspergillus fumigatus promotes tumor angiogenesis via SLC7A11 on myeloid-derived suppressor cells.
Journal: EMBO reports
Published: January 15, 2025
From resistance to sensitivity: the impact of FADD and lncRNA PPFIA1-AS1 on cisplatin treatment in LUSC.
Journal: Cancer gene therapy
Published: December 01, 2024
Inflammation-oriented montmorillonite adjuvant enhanced oral delivery of anti-TNF-α nanobody against inflammatory bowel disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 03, 2024
Different depths of food restriction and high-fat diet refeeding in mice impact host obesity and metabolic phenotypes with correlative changes in the gut microbiota.
Journal: MedComm
Published: November 09, 2023
Last Updated: 09/26/2026